InsiderClue
Insiders · Profile

RiverVest Venture Fund III, L.P.

10% owner at OnKure Therapeutics · 10% owner at SPRUCE BIOSCIENCES. Filing since 14 Oct 2020. CIK 0001601559

OKUR OnKure Therapeutics, Inc. 10% owner · 1 trade SPRB SPRUCE BIOSCIENCES, INC. 10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
OKUR OnKure Therapeutics, Inc.
9 Apr 2021
10% owner
Bought
200,000
$3.00M
9.1%
SPRB SPRUCE BIOSCIENCES, INC.
14 Oct 2020
10% owner
Bought
250,000
$3.75M
13.2%
2 decisions on file.